IL‐10 secreted by ADSCs serves as an important immunosuppressing cytokine in cardiovascular disease,[42] decreasing proinflammatory chemokine production and alleviating the inflammatory microenvironment.[43] Therefore, targeted delivery of DPP‐ADSCs had a synergistic immunomodulatory effect; the reduction of platelet and leukocyte adhesion accompanied by ADSC paracrine secretion of anti‐inflammatory factors. Here, IL10 is linked to cardiovascular disorder.